Results 11 to 20 of about 1,060,953 (240)

Axillary sentinel lymph node biopsy after mastectomy: a case report [PDF]

open access: yesWorld Journal of Surgical Oncology, 2010
Background Sentinel lymph node biopsy has been established as the preferred method for staging early breast cancer. A prior history of mastectomy is felt to be a contraindication.
Leonard R Henry   +9 more
core   +3 more sources

Mastoscopic sentinel lymph node biopsy in breast cancer

open access: yesOpen Medicine, 2015
Background: Previous studies have demonstrated that mastoscopic sentinel lymph node biopsy (MSLNB) has good identification rate (IR) and low false negative rate (FNR).
Qian Liyuan   +7 more
core   +2 more sources

Recent advances and perspectives in the application of repeat sentinel lymph node biopsy in breast cancer patients underwent breast-conserving surgery [PDF]

open access: yesZhongguo aizheng zazhi, 2023
Due to a series of complications associated with traditional axillary lymph node dissection, sentinel lymph node biopsy has now replaced axillary lymph node dissection as the standard axillary staging procedure for patients with negative axillary lymph ...
ZHAO Qian, LING Yunxiao, LIU Guangyu
doaj   +3 more sources

The further assessment of a handheld Raman spectroscopy probe for the intraoperative diagnosis of axillary lymph nodes in breast cancer [PDF]

open access: yes, 2012
Axillary sentinel lymph node biopsy plays an important role in breast cancer management in determining further surgical and medical treatment options.
Tydeman, C.
core   +7 more sources

The use of Raman spectroscopy for the intra-operative assessment of axillary lymph nodes in breast cancer [PDF]

open access: yes, 2012
Breast cancer remains a significant cause of morbidity and mortality. Assessment of the axillary lymph nodes is part of the staging of the disease. Advances in surgical management of breast cancer have seen a move towards intra-operative lymph node ...
Horsnell, Jonathan
core   +7 more sources

Concordance between Axillary Ultrasound and Sentinel Biopsy in Clinically Node-Negative Early Breast Cancer

open access: yesPakistan Armed Forces Medical Journal, 2023
Objective: To determine the sensitivity of axillary ultrasound in detecting axillary nodal metastasis in clinically and radiologically uninvolved axillary nodes in early carcinoma breast by comparing with sentinel node biopsy histopathology on frozen ...
Afroz Mushtaq   +7 more
doaj   +1 more source

Evaluation of Sentinel Lymph Node Biopsy After Primary Chemotherapy as Part of De-Escalation of Breast Cancer Treatment [PDF]

open access: yesResearch in Oncology, 2021
Background: Sentinel lymph node biopsy (SLNB) after primary chemotherapy for node-positive breast cancer patients has been gaining popularity as part of the de-escalation of treatment. Aim: The 1ry aim was to assess the surgical outcome of node-positive
Mohamed I. AbdelAziz, Sherif Monib
doaj   +1 more source

How does the mitotic index impact patients with T1 melanoma? Comparison between the 7th and 8th edition of the American Joint Committee on Cancer melanoma staging system, [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2020
Background: The mitotic index is no longer used to classify T1 melanoma patients into T1a and T1b, so it should not be used to indicate sentinel node biopsy in these patients.
Amanda Zorzetto Antonialli   +5 more
doaj   +1 more source

Characteristics of systematic lymph node dissection and influencing factors of sentinel lymph node biopsy using carbon nanoparticles in endometrial carcinoma: a single-center study

open access: yesWorld Journal of Surgical Oncology, 2023
Background Carbon nanoparticles (CNPs) are a new tracer for lymph node mapping, which can quickly reach and develop lymph nodes through a lymphatic network.
Siqi Tao   +6 more
doaj   +1 more source

Long‐term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

open access: yesBJS (British Journal of Surgery), EarlyView., 2020
This long‐term follow‐up study determined survival rates in a Swedish national cohort of 417 patients with breast cancer who all had neoadjuvant systemic therapy (NAST). Sentinel lymph node biopsy (SLNB) was performed before NAST in clinically node‐negative and after NAST in clinically node‐positive patients.
L. Zetterlund   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy